Document is current
Any future updates will be listed below
-
Authors
Gernert, Michael https://orcid.org/0000-0003-0074-4459
Müller, Tobias https://orcid.org/0000-0003-3035-7070
Schweiker, Lukas
Schmalzing, Marc https://orcid.org/0000-0002-3289-2299
Fröhlich, Matthias https://orcid.org/0000-0001-7745-3903
Nagler, Lea-Kristin
Strunz, Patrick-Pascal https://orcid.org/0000-0002-3168-7074
Labinsky, Hannah https://orcid.org/0000-0001-5762-9182
Schwaneck, Eva Christina https://orcid.org/0000-0003-1935-2092
-
Funding
Funding for this research was provided by:
Universitätsklinikum Würzburg
- License Information
-
More Information
Article History
Received: 6 September 2024
Accepted: 25 November 2024
First Online: 11 December 2024
Declarations
:
: This study was approved by the local ethics committee of the University of Würzburg. All data was generated in compliance with the declaration of Helsinki.
: Not applicable.
: MG received travel grants, compensation for advisory boards or speaker’s fees from AbbVie, Amgen, AstraZeneca, Eli Lilly, Hexal, Janssen, Novartis, Pfizer, Takeda, UCB. TM none. LS none. MS received speaker’s fees, travel grants, research funding, or compensation for consultancies or board memberships from AbbVie, Actelion, AstraZeneca, BMS, Boehringer/Ingelheim, Celgene, Chugai/Roche, Eli Lilly, Genzyme, Gilead, Hexal/Sandoz, Janssen-Cilag, MSD, Novartis, Pfizer, Sanofi Pasteur, Takeda (Shire), UCB. MF received speaker’s fees, travel grants or compensation for board memberships from AbbVie, Novartis, Janssen, and Eli Lilly. LN received travel grant from AbbVie, Medac, and UCB. P-PS received travel grants from AbbVie, Lilly, Euroimmun, Galapagos, and Janssen-Cilag and research founding from Chugai. HL received travel grants, compensation for advisory boards or speaker’s fees from Janssen, Novartis, Abbvie, Pfizer, Alfasigma, Boehringer/Ingelheim, Celltrion and UCB. ECS received speaker’s fees, travel grants, research funding, or compensation for consultancies or board memberships from AstraZeneca, Boehringer-Ingelheim, Janssen, Chugai, Takeda, AbbVie, Novartis, Pfizer, Galapagos, GSK, Amgen, Medac, Otsuka, UCB.
